India had on Thursday said quality tests on the samples lifted from Maiden Pharmaceuticals - which has been in the dock for allegedly causing deaths of children in The Gambia - by the government's Central Drugs Laboratory (CDL) found the products to be in compliance with prescribed specifications and not contaminated with diethylene glycol (DEG) or ethylene glycol (EG).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rLeKPmz
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» 'WHO stands by its action on Gambia cough syrup issue'
0 comments:
Post a Comment